Clinical Trial Update: Evaluation of a Novel Microfluidic Device to Purify Metastatic Lung Cancer Patients CTC (Circulating Tumoral Cells)

View source ↗

Summary

A terminated clinical trial evaluating a novel microfluidic device to purify circulating tumor cells in patients with metastatic non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Non Small Cell Lung Cancer | Status: TERMINATED